MUR
26
-3
KHC
29
2
AVGO
57
-14
SYF
83
-3
KR
50
10
MAT
50
18
HCA
55
2
EW
40
2
WRK
60
-3
ILMN
36
10
SWKS
57
-8
T
45
3
VMC
57
3
NOV
37
-2
SRE
30
-2
AMG
44
-3
ZTS
49
20
UAL
34
-3
SCHW
49
3
O
37
-2
MUR
26
-3
KHC
29
2
AVGO
57
-14
SYF
83
-3
KR
50
10
MAT
50
18
HCA
55
2
EW
40
2
WRK
60
-3
ILMN
36
10
SWKS
57
-8
T
45
3
VMC
57
3
NOV
37
-2
SRE
30
-2
AMG
44
-3
ZTS
49
20
UAL
34
-3
SCHW
49
3
O
37
-2
Financhill
Back

Lincoln National Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
46

LNC
Lincoln National

Last Price:
31.97
Seasonality Move:
1.97%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
46
Lincoln National (LNC) is a Sell

Is Lincoln National a Buy, Sell or Hold?

  • The current Lincoln National [LNC] share price is $31.97. The Score for LNC is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • LNC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LNC Stock Price Chart

What is Lincoln National's stock price today?

  • The Lincoln National share price today is $31.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LNC is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

LNC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.29 Buy
Relative Strength Index (14 RSI): 56.15 Buy
Chaikin Money Flow: 2120468 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (30.8 - 32.66) Buy
Bollinger Bands (100): (26.99 - 31.15) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

LNC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.29 Buy
20-day SMA: 32.02 Sell
50-day SMA: 30.04 Buy
200-day SMA: 26.99 Buy
8-day EMA: 31.57 Buy
20-day EMA: 31.47 Buy
50-day EMA: 30.57 Buy
200-day EMA: 28.54 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Lincoln National Earnings Growth & LNC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.24 per share, an increase this year of $0.78 per share, and an increase next year of $1.69 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Lincoln National Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):